Surufatinib (S) for patients (Pts) with advanced pancreatic neuroendocrine tumours (SANET-p): A randomized, double-blind, placebo (P)-controlled phase III trial (NCT02589821)

Xu, J; Shen, L; Bai, C; Li, J; Zhou, Z; Yu, X; Li, Z; Li, E; Yuan, X; Chi, Y; Yin, Y; Lou, W; Xu, N; Bai, Y; Zhang, T; Xiu, D; Wang, X; Li, J; Fan, S; Su, W

ANNALS OF ONCOLOGY, 2020; 31 (): S770

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索